첫 페이지 News 본문

On September 25th, Southern Finance and Economics reported that GlaxoSmithKline (GSK) confirmed to reporters that starting from today (September 25th), Li Weidong will join GSK China as Vice President and Head of Vaccine Business, reporting directly to Yu Huiming, Vice President and General Manager of GSK China. According to public information, Li Weidong was the Vice General Manager and Operations Manager of Wesker Biotech before joining GlaxoSmithKline. (21st Century Business Herald)
您需要登录后才可以回帖 登录 | Sign Up

本版积分规则

matchinfo 新手上路
  • Follow

    0

  • Following

    0

  • Articles

    0